Skip to content

Serrantor OCT Study

Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06434194
Enrollment
60
Registered
2024-05-30
Start date
2024-10-31
Completion date
2025-06-01
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia

Brief summary

TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.

Interventions

DEVICESerranator PTA Serration Catheter

The Serranator PTA Serration Balloon Catheter is an over-the-wire balloon dilatation catheter designed to perform percutaneous transluminal angioplasty (PTA) for peripheral indications.

A percutaneous transluminal angioplasty catheter will be used to treat the target lesion.

Sponsors

Cagent Vascular LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rutherford clinical category 4-6 of the target limb * Age of subjects is \>18 years old * Patients has given informed consent to participate in this study

Exclusion criteria

* De novo or restenotic (without prior stent) stenosis (≥70%) or occlusion * Target lesion is in the BTK arteries, including below the knee popliteal, tibioperoneal trunk, tibial, peroneal, and pedal arteries. * Angiographic visual estimated reference vessel diameter is between 2.0 and 5.0 mm. * Lesion length less than 220 mm

Design outcomes

Primary

MeasureTime frameDescription
Residual Lumen Volume StenosisBaselineResidual lumen volume stenosis derived by OCT comparing Serration Angioplasty and conventional plain balloon angioplasty (PTA) measured at 10-15min post procedure. The lesion segment is defined as the entire treated segment where the balloon has been inflated.

Secondary

MeasureTime frameDescription
Angiography Residual Diameter StenosisBaselineResidual stenosis as measured by angiography
Dissection PatternBaselineThe incidence of dissection pattern between the study arms as reported by the OCT Corelab. The CoreLab will evaluate OCT images of each dissection including analysis of the length of the dissection, arc of the dissection, number of serrations, and the length of the serration.
OCT Residual Diameter StenosisBaselineResidual stenosis as measured by OCT
Rate of Optimal PTABaselineRate of procedures that achieve optimal PTA (\<30% diameter stenosis without flow-limiting dissection measured by angiography)
Bail-out StentingBaselineRate of bail-out stenting
Correlation of Luminal Gain and Plaque ModificationBaselineThe correlation of the plaque modification achieved as determine from the OCT evaluation after treatment with the Study Device to the luminal gain achieved by conventional angioplasty as evaluated by the Core Lab.

Countries

United States

Contacts

Primary ContactFeeny
kjclinconsulting@gmail.com4197878496
Backup ContactWittwer
twittwer@mededge.io

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026